- Home
- OPXS vs IMMX Comparison
OPXS vs IMMX Comparison
Compare OPXS & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPXS
- IMMX
- Stock Information
- Founded
- OPXS 1987
- IMMX 2014
- Country
- OPXS United States
- IMMX United States
- Employees
- OPXS N/A
- IMMX N/A
- Industry
- OPXS Electronic Components
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- OPXS Technology
- IMMX Health Care
- Exchange
- OPXS Nasdaq
- IMMX Nasdaq
- Market Cap
- OPXS 72.2M
- IMMX 61.1M
- IPO Year
- OPXS N/A
- IMMX 2021
- Fundamental
- Price
- OPXS $11.55
- IMMX $2.65
- Analyst Decision
- OPXS
- IMMX Strong Buy
- Analyst Count
- OPXS 0
- IMMX 1
- Target Price
- OPXS N/A
- IMMX $7.00
- AVG Volume (30 Days)
- OPXS 68.2K
- IMMX 220.7K
- Earning Date
- OPXS 08-12-2025
- IMMX 08-11-2025
- Dividend Yield
- OPXS N/A
- IMMX N/A
- EPS Growth
- OPXS 36.84
- IMMX N/A
- EPS
- OPXS 0.71
- IMMX N/A
- Revenue
- OPXS $37,431,000.00
- IMMX N/A
- Revenue This Year
- OPXS N/A
- IMMX N/A
- Revenue Next Year
- OPXS N/A
- IMMX N/A
- P/E Ratio
- OPXS $16.29
- IMMX N/A
- Revenue Growth
- OPXS 21.76
- IMMX N/A
- 52 Week Low
- OPXS $5.36
- IMMX $1.26
- 52 Week High
- OPXS $14.60
- IMMX $3.20
- Technical
- Relative Strength Index (RSI)
- OPXS 47.93
- IMMX 49.64
- Support Level
- OPXS $11.72
- IMMX $2.63
- Resistance Level
- OPXS $12.62
- IMMX $3.20
- Average True Range (ATR)
- OPXS 1.15
- IMMX 0.22
- MACD
- OPXS -0.26
- IMMX -0.04
- Stochastic Oscillator
- OPXS 16.44
- IMMX 3.51
About OPXS Optex Systems Holdings Inc.
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.